[1]
|
J. C. L. Chow and G. N. Grigorov, “Monte Carlo Simula-tions of Dose near a Nonradioactive Gold Seed,” Medical Physics, Vol. 33, No. 12, 2006, pp. 4614-4621. doi:10.1118/1.2388573
|
[2]
|
W. Newhauser, J. Fontenot, N. Koch, L. Dong, A. Lee, Y. Zheng, L Waters and R. Mohan, “Monte Carlo Simulations of the Dosimetric Impact of Radiopaque Fiducial Markers for Proton Radiotherapy of the Prostate,” Physics in Medicine and Biology, Vol. 52, No. 11, 2007, pp. 2937-2952. doi:10.1088/0031-9155/52/11/001
|
[3]
|
A. Giebeler, J. Fontenot, P. Balter, G. Ciangaru, R. Zhu and W. Newhauser, “Dose Perturbations from Implanted Helical Gold Markers in Proton Therapy of Prostate Cancer,” Journal of Applied Clinical Medical Physics, Vol. 10, 2009, pp. 63-70.
|
[4]
|
J. Cheung, R. J. Kudchadker, X. R. Zhu, A. K. Lee and W. D. Newhauser, “Dose Perturbations and Image Artifacts Caused by Carbon-Coated Ceramic and Stainless Steel Fiducials Used in Proton Therapy for Prostate Cancer,” Physics in Medicine and Biology, Vol. 55, No. 23, 2010, pp. 7135-7147. doi:10.1088/0031-9155/55/23/S13
|
[5]
|
J. Y. Huang, W. D. Newhauser, X. R. Zhu, A. K. Lee and R. J. Kudchadker, “Investigation of Dose Perturbations and the Radiographic Visibility of Potential Fiducials for Proton Radiation Therapy of the Prostate,” Physics in Medicine and Biology, Vol. 56, No. 16, 2011, pp. 5287- 5302. doi:10.1088/0031-9155/56/16/014
|
[6]
|
Y. K. Lim, J. Kwak, D. W. Kim, D. Shin, M. Yoon, S. Park, J. S. Kim, S. H. Ahn, J. Shin and S. B. Lee, “Microscopic Gold Particle-Based Fiducial Markers for Proton Therapy of Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 74, No. 5, 2009, pp. 1609-1616. doi:10.1016/j.ijrobp.2009.02.076
|
[7]
|
R. J. Kudchadker and A. K. Lee, “Effectiveness of Using Fewer Implanted Fiducial Markers for Prostate Target Alignment,” International Journal of Radiation Oncology, Biology, Physics, Vol. 74, No. 4, 2009, pp. 1283-1289. doi:10.1016/j.ijrobp.2009.02.033
|
[8]
|
A. Lomax, “Intensity Modulation Methods for Proton Radiotherapy,” Physics in Medicine and Biology, Vol. 44, No. 1, 1999, pp. 185-205. doi:10.1088/0031-9155/44/1/014
|
[9]
|
J. O. Deasy, D. Shepard and T. R. Mackie, “Distal Edge Tracking: A Proposed Delivery Method for Conformal Proton Therapy Using Intensity Modulation,” Proceedings XIIth ICCR, Salt Lake City, 1997.
|
[10]
|
M. Zhang, D. Westerly and T. Mackie, “Introducing an On-Line Adaptive Procedure for Prostate Image Guided Intensity Modulate Proton Therapy,” Physics in Medicine and Biology, Vol. 56, No. 15, 2011, pp. 4947-4965. doi:10.1088/0031-9155/56/15/019
|
[11]
|
A. Niemierko, “Reporting and Analyzing Dose Distributions: A Concept of Equivalent Uniform Dose,” Medical Physics, Vol. 24, 1997, pp. 103-110. doi:10.1118/1.598063
|
[12]
|
Y. Liao, M. Joiner, Y. Huang and J. Burmeister, “Hypofractionation: What Does It Mean for Prostate Cancer Treatment?” International Journal of Radiation Oncology, Biology, Physics, Vol. 76, 2010, pp. 260-268. doi:10.1016/j.ijrobp.2009.06.043
|
[13]
|
J. Lyman and A. Wolbarst, “Optimization of Radiation Therapy, IV: A Dose-Volume Histogram Reduction Algorithm,” International Journal of Radiation Oncology, Biology, Physics, Vol. 17, No. 2, 1989, pp. 433-436. doi:10.1016/0360-3016(89)90462-8
|
[14]
|
W. Tome and J. Fowler, “On Cold Spots in Tumor Subvolumes,” Medical Physics, Vol. 29, No. 7, 2002, pp. 1590-1598. doi:10.1118/1.1485060
|
[15]
|
http://physics.nist.gov/cgi-bin/Star/compos.pl?ap
|